Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
262.00    2.00 (0.77%)
Bid:
252.00
Ask:
262.00
Spread: 10.00 (3.968%)
Market Cap: £234.64m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Trading Statement

23 Jul 2025 07:00

RNS Number : 1038S
Wilmington PLC
23 July 2025
 

23 July 2025

Wilmington plc

 

Year-end trading update

 

Wilmington plc, (LSE: WIL, 'Wilmington', 'the Group') the provider of data, information, education and training in the global Governance, Risk and Compliance ('GRC') markets, today provides a trading update for the year ended 30 June 2025.

 

Revenue growth from the Group's ongoing* businesses is expected to be 11%, led by both recent acquisitions in the HSE sector delivering double-digit percentage growth.

 

As at the half year, seven out of nine businesses grew year on year. Following the portfolio changes last year of two disposals and two acquisitions, and the continuing disruption in the US healthcare insurance market impacting our US events business over a full year, reported revenue is expected to be £101.5m (2024: £126m), with organic** revenue also having decreased 1% due to the US.

 

Operating profit from ongoing* businesses is expected to be up 11%, adjusted*** profit before tax is expected to be £27.7m (2024: £27.6m), with adjusted PBT margin up to 27% (2024: 22%).

 

Cash conversion continued to be strong at 107% of profits, with Group net cash on 30 June 2025 at £41.9m (30 June 2024: £67.8m) after the completion of the acquisition of Phoenix Health & Safety on 25 October 2024 and spending £3.4m on share buybacks.

 

Wilmington expects to publish its year end results on 22 September 2025.

 

Mark Milner, Chief Executive Officer, commented:

 

"We have seen another year of good ongoing* revenue and profit growth with both measures increasing 11%, reflecting our focus on a slimmed down higher quality portfolio of growing businesses. Margins have also continued to improve and both of our recent acquisitions have seen double digit growth. This performance came against a tough macro backdrop, particularly in the US healthcare market which has seen continued disruption in the course of our H2.

 

"With the acquisition of Phoenix, we have continued to actively manage our portfolio of businesses and are pursuing various opportunities to invest our cash in acquisitions to improve the quality of revenue and profits."

 

*Ongoing - eliminating the effects of the impact of disposals, closures and businesses held for sale.

**Organic - Ongoing, eliminating acquisitions and exchange rate fluctuations

***Adjusted profit before tax (PBT) is calculated as PBT after adding back amortisation and impairment of intangible assets (except computer software) and profits/losses on disposals and business closures. Market consensus adjusted profit before tax is £27.0m.

 

For further information, please contact:

 

Wilmington plc

Mark Milner, Chief Executive Officer

Guy Millward, Chief Financial Officer

 

Meare Consulting

Adrian Duffield

 

 

020 7490 0049

 

 

 

 

07990 858548

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement this inside information is now considered to be in the public domain.

 

Notes to Editors

Wilmington plc is the recognised knowledge leader and partner of choice for data, information, education and training in the global Governance, Risk and Compliance (GRC) markets. Wilmington employs around 600 people and sells to around 120 countries. Wilmington is listed on the main market of the London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUUUORVWUBUAR
Date   Source Headline
14th Aug 20201:38 pmRNSHolding(s) in Company
15th Jul 20202:08 pmRNSHolding(s) in Company
3rd Jul 20204:36 pmRNSPrice Monitoring Extension
2nd Jul 20206:30 pmRNSHolding(s) in Company
2nd Jul 20206:28 pmRNSHolding(s) in Company
2nd Jul 20206:23 pmRNSHolding(s) in Company
25th Jun 20207:00 amRNSPre-close Trading Update and Banking Arrangements
28th May 202010:18 amRNSHolding(s) in Company
21st May 20204:49 pmRNSHolding(s) in Company
20th May 20204:40 pmRNSSecond Price Monitoring Extn
20th May 20204:35 pmRNSPrice Monitoring Extension
13th May 20201:47 pmRNSHolding(s) in Company
2nd Apr 20207:00 amRNSEmployee Share Ownership Trust Purchase
27th Mar 202011:14 amRNSDirector/PDMR Shareholding
26th Mar 20204:18 pmRNSDirector/PDMR Shareholding
25th Mar 20207:00 amRNSUpdate on COVID-19 Coronavirus Impact and Dividend
9th Mar 202010:02 amRNSEmployee Share Ownership Trust Purchase
9th Mar 20207:00 amRNSUpdate on COVID-19 Coronavirus
3rd Mar 20208:51 amRNSTotal Voting Rights
24th Feb 20204:41 pmRNSSecond Price Monitoring Extn
24th Feb 20204:36 pmRNSPrice Monitoring Extension
20th Feb 20207:00 amRNSDirectorate Change
20th Feb 20207:00 amRNSDirectorate Change
20th Feb 20207:00 amRNSHalf-year Report
20th Feb 20207:00 amRNSHalf-year Report
13th Feb 20202:22 pmRNSEmployee Share Ownership Trust Purchase
9th Jan 20209:20 amRNSEmployee Share Ownership Trust Purchase
2nd Jan 20209:02 amRNSTotal Voting Rights
19th Dec 201910:35 amRNSEmployee Share Ownership Trust Purchase
16th Dec 20193:19 pmRNSHolding(s) in Company
6th Dec 20193:16 pmRNSHolding(s) in Company
3rd Dec 20192:40 pmRNSEmployee Share Ownership Trust Purchase
2nd Dec 201910:44 amRNSTotal Voting Rights
2nd Dec 20199:07 amRNSEmployee Share Ownership Trust Purchase
25th Nov 201910:49 amRNSHolding(s) in Company
5th Nov 201912:57 pmRNSResult of AGM
5th Nov 20197:00 amRNSAGM Statement and Q1 Trading Update
1st Nov 20197:00 amRNSTotal Voting Rights
31st Oct 20194:35 pmRNSPrice Monitoring Extension
3rd Oct 20193:48 pmRNSDirector/PDMR Shareholding
1st Oct 20193:06 pmRNSDirector/PDMR Shareholding
1st Oct 20197:00 amRNSVoting Rights and Capital
20th Sep 20193:05 pmRNSDirector/PDMR Shareholding
19th Sep 20191:37 pmRNSREPLACEMENT: Share Awards
19th Sep 201911:59 amRNSShare Awards
19th Sep 20197:00 amRNSFinancial results for the year ended 30 June 2019
2nd Sep 201910:51 amRNSVoting Rights and Capital
22nd Aug 20193:03 pmRNSHolding(s) in Company
1st Aug 20197:00 amRNSTotal Voting Rights
9th Jul 20194:49 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.